Advancing sustainable R&D in a time of uncertainty

From October 2025 through February 2026, Tapestry Networks spoke with life sciences and health sector leaders about the current landscape for biopharmaceutical research and development (R&D). Conversations focused on fostering an environment for sustainable R&D and innovation at a time when the sector is facing significant changes, especially in the US.

This Summary of Themes provides a brief overview of the analysis from those conversations, integrated with insights from Tapestry’s Fortune 100 board director forums and broader health-sector work.